stem cells news
Microglia, critical to Alzheimer’s research, can now be produced artificially The quest for better understanding of Alzheimer’s disease (AD) has a powerful new tool at its disposal — the ability to artificially generate brain cells that have been shown to play an important role in the disease function.
Two researchers at the Montreal Neurological Institute and Hospital (MNI) of McGill University have received funding to study a devastating neurodegenerative disease that first appears in toddlers just as they are beginning to walk.
Millions of Canadians are affected by diseases of the brain such as ALS, Parkinson’s and brain tumours, for which there are limited treatments and no cures. By 2020, neurological conditions will become the leading cause of death and disability.
Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease A new study by Multiple Sclerosis researchers at three leading Canadian centres addresses why bone marrow transplantation (BMT) has positive results in patients with particularly aggressive forms of MS. The transplantation treatment, which is performed as part of a clinical trial and carries potentially serious risks, virtually stops all new relapsing activity as observed upon clinical examination and brain MRI scans. The study reveals how th